Adipocyte G Protein–Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs
Diabetes · 2023
DOI: 10.2337/db23-0095 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, 2023. Verfasst von Liu Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Adipocytes, Beige. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The functional state of adipocytes plays a central role in regulating numerous important metabolic functions, including energy and glucose homeostasis. While white adipocytes store excess calories as fat (triglycerides) and release free fatty acids as a fuel source in times of need, brown and beige adipocytes (so-called thermogenic adipocytes) convert chemical energy stored in substrates (e.g., fatty acids or glucose) into heat, thus promoting energy expenditure. Like all other cell types, adipocytes express many G protein–coupled receptors (GPCRs) that are linked to four major functional classes of heterotrimeric G proteins (Gs, Gi/o, Gq/11, and G12/13). During the past few years, novel experimental approaches, including the use of chemogenetic strategies, have led to a series of important new findings regarding the metabolic consequences of activating or inhibiting distinct GPCR/G protein signaling pathways in white, brown, and beige adipocytes. This novel information should guide the development of novel drugs capable of modulating the activity of specific adipocyte GPCR signaling pathways for the treatment of obesity, type 2 diabetes, and related metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
ORCID-Profile: Jürgen Wess
Zitieren
APA
Liu, L., & Wess, J. (2023). Adipocyte G Protein–Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs. Diabetes. https://doi.org/10.2337/db23-0095
Vancouver
Liu L, Wess J. Adipocyte G Protein–Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs. Diabetes. 2023. doi:10.2337/db23-0095
BibTeX
@article{Liu2023,
author = {Liu, Liu and Wess, Jürgen},
title = {Adipocyte G Protein–Coupled Receptors as Potential Targets for Novel Antidiabetic Drugs},
journal = {Diabetes},
year = {2023},
doi = {10.2337/db23-0095}
}
EUVIMED